Dashboard
Manage Tickers

PXP10, Inc.

NYSE p10alts.com


$ 7.62 $ -0.04 (-0.52 %)    

Wednesday, 08-May-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 7.59
$ 7.50
$ 0.00 x 0
$ 0.00 x 0
$ 7.44 - $ 7.63
$ 7.08 - $ 13.28
358,871
na
881.23M
$ 0.74
nm
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-13-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-27-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 03-18-2022 12-31-2021 10-K
10 11-22-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

p10-appoints-luke-sarsfield-to-chairman-effective-june-14-2024-announces-termination-of-stockholder-rights-plan
P10 Appoints Luke Sarsfield To Chairman, E...
05/08/2024 22:01:51

Appoints Luke Sarsfield to Chairman, Effective in June Improves Governance Policy Through Termination of Stockholder Rights Pla...

p10-q1-2024-adj-eps-021-beats-019-estimate-sales-66115m-beat-63962m-estimate
P10 Q1 2024 Adj EPS $0.21 Beats $0.19 Esti...
05/08/2024 21:18:24

P10 (NYSE:PX) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.19 by 10.53 percen...

in-depth-examination-of-6-analyst-recommendations-for-p10
In-Depth Examination Of 6 Analyst Recommen...
03/04/2024 15:01:57

oppenheimer-maintains-outperform-on-p10-lowers-price-target-to-11
Oppenheimer Maintains Outperform on P10, L...
03/04/2024 13:49:59

Oppenheimer analyst Chris Kotowski maintains P10 (NYSE:PX) with a Outperform and lowers the price target from $17 to $11.

barclays-maintains-overweight-on-p10-lowers-price-target-to-95
Barclays Maintains Overweight on P10, Lowe...
03/04/2024 11:42:32

Barclays analyst Benjamin Budish maintains P10 (NYSE:PX) with a Overweight and lowers the price target from $14 to $9.5.

morgan-stanley-downgrades-p10-to-equal-weight-lowers-price-target-to-9
Morgan Stanley Downgrades P10 to Equal-Wei...
03/04/2024 10:57:13

Morgan Stanley analyst Michael Cyprys downgrades P10 (NYSE:PX) from Overweight to Equal-Weight and lowers the price target f...

why-zscaler-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Zscaler Shares Are Trading Lower By 10...
03/01/2024 18:19:25

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

jp-morgan-downgrades-p10-to-neutral-lowers-price-target-to-95
JP Morgan Downgrades P10 to Neutral, Lower...
03/01/2024 12:54:12

JP Morgan analyst Ken Worthington downgrades P10 (NYSE:PX) from Overweight to Neutral and lowers the price target from $15.5...

keefe-bruyette--woods-downgrades-p10-to-market-perform-announces-10-price-target
Keefe, Bruyette & Woods Downgrades P10 to ...
03/01/2024 11:08:58

Keefe, Bruyette & Woods analyst Robert Lee downgrades P10 (NYSE:PX) from Outperform to Market Perform and announces $10 ...

p10-board-of-directors-approved-40m-stock-repurchase-program
P10 Board of Directors Approved $40M Stock...
02/29/2024 21:51:28

p10-q4-earnings-insights
P10: Q4 Earnings Insights
02/29/2024 21:35:28

p10-q4-2023-gaap-eps-0210-inline-sales-63067m-beat-62582m-estimate
P10 Q4 2023 GAAP EPS $0.210, Inline, Sales...
02/29/2024 21:35:20

P10 (NYSE:PX) reported quarterly earnings of $0.210 per share which met the analyst consensus estimate. The company reported q...

earnings-scheduled-for-february-29-2024
Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

morgan-stanley-maintains-overweight-on-p10-lowers-price-target-to-12
Morgan Stanley Maintains Overweight on P10...
01/24/2024 20:10:26

Morgan Stanley analyst Michael Cyprys maintains P10 (NYSE:PX) with a Overweight and lowers the price target from $13 to $12.

oppenheimer-reiterates-outperform-on-p10-maintains-15-price-target
Oppenheimer Reiterates Outperform on P10, ...
11/13/2023 17:45:24

Oppenheimer analyst Chris Kotowski reiterates P10 (NYSE:PX) with a Outperform and maintains $15 price target.

expert-ratings-for-p10
Expert Ratings for P10
11/10/2023 20:00:23

stephens--co-maintains-overweight-on-p10-lowers-price-target-to-15
Stephens & Co. Maintains Overweight on P10...
11/10/2023 15:39:19

Stephens & Co. analyst John Campbell maintains P10 (NYSE:PX) with a Overweight and lowers the price target from $16 to $15.

p10-q3-adj-eps-020-beats-018-estimate-sales-5894m-miss-5973m-estimate
P10 Q3 Adj EPS $0.20 Beats $0.18 Estimate,...
11/09/2023 21:47:36

P10 (NYSE:PX) reported quarterly Adj earnings of $0.20 per share which beat the analyst consensus estimate of $0.18 by 11.11 pe...

recap-p10-q3-earnings
Recap: P10 Q3 Earnings
11/09/2023 21:40:39

earnings-scheduled-for-november-9-2023
Earnings Scheduled For November 9, 2023
11/09/2023 11:52:51

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION